Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gary L. Diamond, Nicholas P. Skoulis, A. Robert Jeffcoat & J Frank Nash. (2021) A Physiological-Based Pharmacokinetic Model For The Broad Spectrum Antimicrobial Zinc Pyrithione: II. Dermal Absorption And Dosimetry In The Rat. Journal of Toxicology and Environmental Health, Part A 84:15, pages 609-631.
Read now
Read now
Gary L. Diamond, Nicholas P. Skoulis, A. Robert Jeffcoat & J. Frank Nash. (2017) A physiologically based pharmacokinetic model for the broad-spectrum antimicrobial zinc pyrithione: I. Development and verification. Journal of Toxicology and Environmental Health, Part A 80:2, pages 69-90.
Read now
Read now
Andrea N Edginton, Frank-Peter Theil, Walter Schmitt & Stefan Willmann. (2008) Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opinion on Drug Metabolism & Toxicology 4:9, pages 1143-1152.
Read now
Read now
Miyoung Yoon, MichaelC. Madden & HughA. Barton. (2007) Extrahepatic Metabolism by CYP2E1 in PBPK Modeling of Lipophilic Volatile Organic Chemicals: Impacts on Metabolic Parameter Estimation and Prediction of Dose Metrics. Journal of Toxicology and Environmental Health, Part A 70:18, pages 1527-1541.
Read now
Read now
Ivan Nestorov. (2007) Whole-body physiologically based pharmacokinetic models. Expert Opinion on Drug Metabolism & Toxicology 3:2, pages 235-249.
Read now
Read now
Articles from other publishers (23)
Mengting Chen, Ruihu Du, Tao Zhang, Chutao Li, Wenqiang Bao, Fan Xin, Shaozhang Hou, Qiaomei Yang, Li Chen, Qi Wang & An Zhu. (2023) The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment. Toxics 11:10, pages 874.
Crossref
Crossref
Tetyana Kobets & Gary M. Williams. 2003. Patty's Toxicology. Patty's Toxicology
1
22
.
. 2020. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables. ANSI/AAMI/ISO 10993-16:2017; Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables.
Tetyana Kobets, Michael J. Iatropoulos & Gary M. Williams. (2019) Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment. Toxicology Research 8:2, pages 123-145.
Crossref
Crossref
Tomonori Miura, Shotaro Uehara, Mayuko Nakazato, Takashi Kusama, Akiko TodaYusuke Kamiya, Norie Murayama, Makiko Shimizu, Hiroshi Suemizu & Hiroshi Yamazaki. (2019) Human plasma and liver concentrations of styrene estimated by combining a simple physiologically based pharmacokinetic model with rodent data. The Journal of Toxicological Sciences 44:8, pages 543-548.
Crossref
Crossref
G. Johanson. 2018. Comprehensive Toxicology. Comprehensive Toxicology
165
187
.
Christopher J. Borgert, Kimberly Wise & Richard A. Becker. (2015) Modernizing problem formulation for risk assessment necessitates articulation of mode of action. Regulatory Toxicology and Pharmacology 72:3, pages 538-551.
Crossref
Crossref
Sloane K. Tilley & Rebecca C. Fry. 2015. Systems Biology in Toxicology and Environmental Health. Systems Biology in Toxicology and Environmental Health
117
169
.
Frank Barile. 2013. Principles of Toxicology Testing, Second Edition. Principles of Toxicology Testing, Second Edition
8
22
.
Michael A. Lyons, Brad Reisfeld, Raymond S. H. Yang & Anne J. Lenaerts. (2013) A Physiologically Based Pharmacokinetic Model of Rifampin in Mice. Antimicrobial Agents and Chemotherapy 57:4, pages 1763-1771.
Crossref
Crossref
Kannan Krishnan, Brooks McPhail, Weihsueh Chiu & Paul White. 2013. Computational Toxicology. Computational Toxicology
45
66
.
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
383
399
.
John C. Lipscomb, Sami Haddad, Torka Poet & Kannan Krishnan. 2012. New Technologies for Toxicity Testing. New Technologies for Toxicity Testing
76
95
.
Lucila Garcia-Contreras. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
443
474
.
Ryohji Takano, Norie Murayama, Kana Horiuchi, Masato Kitajima, Fumiaki ShonoHiroshi Yamazaki. (2010) Blood Concentrations of 1,4-Dioxane in Humans after Oral Administration Extrapolated from In Vivo Rat Pharmacokinetics, In Vitro Human Metabolism, and Physiologically Based Pharmacokinetic Modeling. Journal of Health Science 56:5, pages 557-565.
Crossref
Crossref
G. Johanson. 2010. Comprehensive Toxicology. Comprehensive Toxicology
153
177
.
Weihsueh A. Chiu, Miles S. Okino & Marina V. Evans. (2009) Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach. Toxicology and Applied Pharmacology 241:1, pages 36-60.
Crossref
Crossref
Ashley Roberts & Andrew G. Renwick. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Mitchell J. Small. (2008) Methods for Assessing Uncertainty in Fundamental Assumptions and Associated Models for Cancer Risk Assessment. Risk Analysis 28:5, pages 1289-1308.
Crossref
Crossref
John C. Lipscomb & Torka S. Poet. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology & Therapeutics 118:1, pages 82-103.
Crossref
Crossref
Yasong Lu, Susan Rieth, Manupat Lohitnavy, James Dennison, Hisham El-Masri, Hugh A. Barton, James Bruckner & Raymond S.H. Yang. (2008) Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane. Regulatory Toxicology and Pharmacology 50:2, pages 249-260.
Crossref
Crossref
Frank Barile. 2007. Principles of Toxicology Testing. Principles of Toxicology Testing
11
25
.
Robert De Woskin, Chadwick Thompson, Weihsueh Chiu, Paul Schlosser, Carolyn Smallwood, Jeff Swartout, Linda Teuschler & Allan Marcus. 2006. Toxicokinetics and Risk Assessment. Toxicokinetics and Risk Assessment
301
348
.